Naturally Occurring NF-&kgr;B Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|6|8|945-951

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.8, 2006-08, pp. : 945-951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-&kgr;B in Type 1 Diabetes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr; B and Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 359-372

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Strategies to Modulate the NF-&kgr;B and JNK Signal Transduction Network

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-02 ,pp. : 71-84

Bentham Science Publishers

Access to resources Recommend Favorite

Damnacanthal-Induced Anti-Inflammation is Associated with Inhibition of NF-&kgr;B Activity

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 455-463

Bentham Science Publishers

Access to resources Recommend Favorite